A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).

Clinical trial NCT01153399 · COMPLETED

Trial details

NCT number: NCT01153399
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2010-10-01
Primary completion: 2014-12-01
Enrollment: 589

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.